Telavancin how supplied: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Telavancin}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==HOW SUPPLIED/STORAGE AND HANDLING== | |||
*Cartons of 10 individually packaged 250 mg single-dose vials (NDC 0469-3525-30) | |||
*Cartons of 10 individually packaged 750 mg single-dose vials (NDC 0469-3575-50) | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e7c066c-0950-47ce-899d-76881d80c492 | publisher = | date = | accessdate = }}</ref> | Store original packages at refrigerated temperatures of 2 to 8°C (35 to 46 °F). Excursions to ambient temperatures (up to 25 °C (77 °F)) are acceptable. Avoid excessive heat.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e7c066c-0950-47ce-899d-76881d80c492 | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 00:05, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
HOW SUPPLIED/STORAGE AND HANDLING
- Cartons of 10 individually packaged 250 mg single-dose vials (NDC 0469-3525-30)
- Cartons of 10 individually packaged 750 mg single-dose vials (NDC 0469-3575-50)
Store original packages at refrigerated temperatures of 2 to 8°C (35 to 46 °F). Excursions to ambient temperatures (up to 25 °C (77 °F)) are acceptable. Avoid excessive heat.[1]
References
Adapted from the FDA Package Insert.